Translational Science author instructions page. The data presented herein are consistent with cardiomyocyte-specific deletion of GCRG (10), demonstrating that heart-specific elimination of GCGR signaling reduces mortality that is induced by experimental ischemia in normal mice.
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However, there are some experimental caveats and questions that need to be explored further.
Glucagon was administered as 4 injections a day for the first 6 days to post-MI mice and is expected to increase glucose production with changes in overall metabolic status (5). Also, a placebo group to control for vehicle composition and frequency of administration was not included in this study. Consistent with the above-mentioned metabolic changes in normal mice, the authors reported decreased fasting plasma glucose in mice treated with REMD2.59. Although the animals were nondiabetic, and the injury was localized to the heart, it is unclear if these metabolic changes contributed to the effects observed.
An important consideration is the potential for transability of these findings from mice to humans. Glucagon and Heart Failure A P R I L 2 0 1 9 : 1 7 3 -5
